Cobalamin conjugates useful as imaging and therapeutic agents

Details Cobalamin conjugates useful as imaging and therapeutic agents Cobalamin conjugates useful as imaging and therapeutic agents

2007-02-20

2007-02-20

Jones, Dameron L. (Department: 1618)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

C424S001110, C424S001650, C424S009100, C424S001810, C424S001730, C534S010000, C534S014000, C536S026400

Reexamination Certificate

active

10785266

ABSTRACT:
The invention provides detectably labeled cobalamin derivatives which are useful for medical treatment and diagnosis.

REFERENCES:
patent: 3627788 (1971-12-01), Bouchaudon
patent: 3936440 (1976-02-01), Nath
patent: 3981863 (1976-09-01), Niswender et al.
patent: 4209614 (1980-06-01), Bernstein et al.
patent: 4279859 (1981-07-01), Gutcho et al.
patent: 4283342 (1981-08-01), Yollees
patent: 4301140 (1981-11-01), Frank et al.
patent: 4465775 (1984-08-01), Houts
patent: 4612302 (1986-09-01), Szabo et al.
patent: 4684620 (1987-08-01), Hruby et al.
patent: 4853371 (1989-08-01), Coy et al.
patent: 5308606 (1994-05-01), Wilson et al.
patent: 5405598 (1995-04-01), Schinazi et al.
patent: 5405839 (1995-04-01), Toraya et al.
patent: 5428023 (1995-06-01), Russell-Jones et al.
patent: 5449720 (1995-09-01), Russell-Jones et al.
patent: 5462724 (1995-10-01), Schinazi et al.
patent: 5514695 (1996-05-01), Bergeron
patent: 5548064 (1996-08-01), Russell-Jones et al.
patent: 5574018 (1996-11-01), Habberfield et al.
patent: 5589463 (1996-12-01), Russell-Jones et al.
patent: 5599796 (1997-02-01), Schinazi et al.
patent: 5608060 (1997-03-01), Axworthy et al.
patent: 5739313 (1998-04-01), Collins et al.
patent: 5807832 (1998-09-01), Russell-Jones et al.
patent: 5840880 (1998-11-01), Morgan, Jr. et al.
patent: 5869465 (1999-02-01), Morgan, Jr. et al.
patent: 5869466 (1999-02-01), Russell-Jones et al.
patent: 5872107 (1999-02-01), Schinazi et al.
patent: 5877165 (1999-03-01), Miura et al.
patent: 5936082 (1999-08-01), Bauer
patent: 6004533 (1999-12-01), Collins et al.
patent: 6074625 (2000-06-01), Hawthorne et al.
patent: 6083926 (2000-07-01), Morgan et al.
patent: 6083966 (2000-07-01), Bergeron, Jr.
patent: 6096290 (2000-08-01), Collins et al.
patent: 6150341 (2000-11-01), Russell-Jones et al.
patent: 6180766 (2001-01-01), Schinazi et al.
patent: 6211355 (2001-04-01), Collins et al.
patent: 6262253 (2001-07-01), Russell-Jones et al.
patent: 6315978 (2001-11-01), Grissom et al.
patent: 6613305 (2003-09-01), Collins et al.
patent: 6806363 (2004-10-01), Collins et al.
patent: 6838073 (2005-01-01), Collins et al.
patent: 2002/0042394 (2002-04-01), Hogenkamp et al.
patent: 2002/0049155 (2002-04-01), Hogenkamp
patent: 2002/0151525 (2002-10-01), Collins et al.
patent: 2003/0018009 (2003-01-01), Collins
patent: 2003/0144198 (2003-07-01), Collins
patent: 04490099 (2000-01-01), None
patent: 1811518 (1969-07-01), None
patent: 0 005 834 (1979-12-01), None
patent: 0 069 450 (1983-01-01), None
patent: 0 165 716 (1985-12-01), None
patent: 58-046027 (1983-03-01), None
patent: WO 89/01475 (1989-02-01), None
patent: WO 92/09610 (1992-06-01), None
patent: WO 92/13571 (1992-08-01), None
patent: WO 94/27613 (1994-12-01), None
patent: WO 94/27641 (1994-12-01), None
patent: WO 96/27641 (1994-12-01), None
patent: WO 95/27723 (1995-10-01), None
patent: WO 96/04016 (1996-02-01), None
patent: WO 96/31243 (1996-10-01), None
patent: WO 97/14711 (1997-04-01), None
patent: WO 97/18231 (1997-05-01), None
patent: WO 97/33627 (1997-09-01), None
patent: WO 98/08859 (1998-03-01), None
patent: WO 99/65930 (1999-12-01), None
patent: WO 00/45857 (2000-08-01), None
patent: WO 00/62808 (2000-10-01), None
patent: WO 00/74721 (2000-12-01), None
patent: WO 01/28592 (2001-04-01), None
patent: WO 01/28595 (2001-04-01), None
patent: WO 01/30967 (2001-05-01), None
patent: WO 01/92283 (2001-12-01), None
patent: WO 01/92288 (2001-12-01), None
patent: WO 02/042318 (2002-05-01), None
patent: WO 02/055530 (2002-07-01), None
patent: WO 03/000010 (2003-01-01), None
patent: WO 03/025139 (2003-03-01), None
Alam, G. et al., “Boronated compounds for neutron capture therapy,”Strahlentherapie und Onkologie, 165(2/3):121-123 (1989).
Allen, R.H., et al., “Isolation of gastric vitamin B12-binding proteins using affinity chromatrography,”J. Biol. Chem., 248(10):3660-3669 (May 25, 1973).
Allen, R.H., et al., “Isolation of vitamin B12-binding proteins using affinity chromatography,”J. Biol. Chem., 247(23):7695-7701 (Dec. 10, 1972).
Amagasaki, T., et al., “Expression of transcobalamin II receptors by human leukemia K562 and HL-60 cells,”Blood, 76(7):1380-1386, (Oct. 1, 1990).
Anton, D.L., et al., “Carbon-13 nuclear magnetic resonance studies of the monocarboxylic acids of cyanocobalamin. Assignments of the B-, D-, and E-monocarboxylic acids,”J. Am. Chem. Soc., 102(7):2215-2219 (Mar. 26, 1980).
Anton, D.L., et al., “The synthesis and properties of four spin-labled analogs of adenosylcobalamin,”J. Biol. Chem. 255(10):4507-4510 (May 25, 1980).
Begley, J.A. et al., “Cobalamin metabolism in cultured human chorionic villus cells,”J. Cell Physiol., 156(1):43-47 (Jul. 1993).
Bernhauer, K., et al., “Zur Chemie und Biochemie der Corrinoide,”Biochem. Z., 344:289-309 (1966).
Blomquist, L., et al., “Uptake of labelled vitamin B 12 and 4-iodophenylalanine in some tumors of mice,”Experientia, 25(3):294-296 (Mar. 15, 1969).
Breeman, W.A., et al., “Indium-111 labeled DTPA- and DOTA-bombesin analogs for receptor scintigraphy and radiothereapy,” in Scientific Papers (Jun. 9, 1999), Proc. of the 46thAnnual Meeting of the Society of Nuclear Medicine (Los Angeles, California, Jun. 6-10, 1999),J. Nuc. Med., 40(5):102P, Abstract No. 413 (May 1999 supplement).
Broan, C. J., et al., “Synthesis and complexation behaviour of an effective octadentate complexone 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis[methylene(methylphosphinic acid)],”J. Chem. Soc. Chem. Comm., 23:1739-1741 (1990).
Collins, D.A., et al., “Transcobalamin II receptor imaging via radiolabeled diethylene-triaminepentaacetate cobalamin analogs,”J. Nucl. Med., 38(5):717-723 (May 1997).
Collins, D.A., et al., “Tumor imaging via indium 111-labeled DTPA-adenosylcobalamin,”Mayo Clinic Proc., 74(7):687-691 (Jul. 1999).
Cooper, B.A., et al., “Selective uptake of specifically bound cobalt-58 vitamin B12 by human and mouse tumour cells,”Nature, 191, 393-395 (Jul. 1961).
De jong, M., et al., “Radionuclide therapy using radiolabeled somatostatin analogs in tumor-bearing rats,” in Scientific Papers (Jun. 9, 1999), Proc. of the 46thAnnual Meeting of the Society of Nuclear Medicine (Los Angeles, California, Jun. 6-10, 1999),J. Nuc.Med., 40(5):102, Abstract No. 414 (May 1999 Supplement).
Ellenbogen, L, “Absorption and transport of cobalamin: Intrinsic factor and the transcobalamins,”Cobalamin: Biochemistry and Pathophysiology, Babior, Ed., Wiley, New York (1975), Chapter 5.
Fairchild, R.G., et al., “Current status of 10-B-neutron capture therapy: enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: A theoretical evaluation,”Int. J. Radiation Oncology, Biology, Physics, 11(4):831-840 (Apr. 1985).
Finkler, A.E., et al., “Nature of the relationship between vitamin B12 binding and cell uptake,”Arch. Biochem. Biophys., 120(1):79-85 (Apr. 1967).
Flodh, H., et al., “Accumulation of labelled vitamin B12 in some transplanted tumours,”Int. J. Cancer: 3(5):694-699 (Sep. 15, 1968).
Gabel, D., “Tumor-Seeking Compounds for Boron Neutron Capture Therapy: Synthesis and Biodistribution,”Clinical Aspects of Neutron Capture Therapy, Ralph G. Fairchild et al., eds.; Plenum Press, New York, 233-241, 1987.
Gabel, D., et al., “Monte Carlo simulation of the biological effect of the10B(n,α)7Li reaction in cells and tissue and its implication for boron neutron capture therapy,”Radiation Research, 111:14-25 (1987).
Hall, C.A., et al., “Cyclic activity of the receptors of cobalamin bound to transcobalamin II,”J. Cell Physiol., 133(1):187-191 (Oct. 1987).
Hatanaka, H., “A revised boron-neutron capture therapy for malignant brain tumors,”Journal of Neurology, 209:81-94 (1975).
Hatanaka, H., et al., “Chapter XXV: Clinical Experience of Boron-Neuron Capture Therapy for Glioma

Affiliated with

Also associated with

Rating

Cobalamin conjugates useful as imaging and therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cobalamin conjugates useful as imaging and therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cobalamin conjugates useful as imaging and therapeutic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3873301